CURE

•

Equity

VANECK GENOMICS AND HEALTHCARE INNOVATORS UCITS ETF

TER (bps):

35

AUM (USD m):

7

ISIN:

IE000B9PQW54

Domicile:

Ireland

Share Class Currency:

USD

ESG:

No

Geographical Focus:

Global

As of:

26 Sep 2024

Climate Fund:

No

Benchmark

The MVIS Global Future Healthcare ESG Index is a global index that tracks the performance of companies that are involved in the genomic health care and electronic healthcare industries. The index is a modified market cap-weighted index with pure-play exposure. MVFHC covers at least 90% of the investable universe.

PERFORMANCE

Powered byhttps://www.etfbook.com/ logo

RELATED ARTICLES

People moves new hires
People Moves

VanEck shifts product manager to German ETF sales team

Schmaus spent almost a decade in product management

Jamie Gordon

Martijn Rozemuller
New Listing

VanEck launches Europe’s first bionic healthcare ETF

The firm has launched two healthcare thematic ETFs within three months

Jamie Gordon

a sign on a rock
New Listing

VanEck launches circular economy ETF

REUS takes the firm’s launch count to 13 so far in 2022

Jamie Gordon

MOST READ

1
New Listing

American Century marks European entry with double active ETF launch

Jamie Gordon

2
Industry Updates

ARK Invest teams up with eToro to launch portfolio of ETFs

Lauren Gibbons

3
New Listing

BNP Paribas AM hires UK sales head and lists first four ETFs on LSE

Jamie Gordon

4
New Listing

The Intesa Sanpaolo Group enters the ETF market with six launches

Toby Lawes

5
Analysis

Which sectors and factors outperform in wartime?

Nicolas Rabener